Parkwood LLC’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,477
Closed -$1.8M 171
2023
Q3
$1.8M Sell
8,477
-90
-1% -$18K 0.2% 66
2023
Q2
$1.65M Sell
8,567
-4,051
-32% -$805K 0.3% 65
2023
Q1
$2.56M Buy
12,618
+56
+0.4% +$8.98K 0.35% 60
2022
Q4
$1.61M Buy
12,562
+2,614
+26% +$337K 0.24% 76
2022
Q3
$1.36M Sell
9,948
-415
-4% -$67.6K 0.21% 85
2022
Q2
$1.83M Sell
10,363
-4,670
-31% -$673K 0.33% 73
2022
Q1
$2.17M Buy
15,033
+464
+3% +$62.8K 0.36% 67
2021
Q4
$2.25M Sell
14,569
-7,217
-33% -$1.21M 0.38% 66
2021
Q3
$3.7M Buy
21,786
+1,620
+8% +$252K 0.45% 62
2021
Q2
$3.18M Sell
20,166
-2,281
-10% -$339K 0.37% 65
2021
Q1
$3.12M Buy
22,447
+9,504
+73% +$1.53M 0.55% 54
2020
Q4
$2.27M Buy
+12,943
New +$2.41M 0.27% 72

Other funds holding SGEN

Parkwood LLC's SGEN Position: Q4 2023 in Review

Parkwood LLC sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 8,477 shares — an estimated $1.8M sold.

Parkwood LLC first reported a position in SGEN in Q4 2020 and held it in 12 quarters. The position peaked at $3.7M in Q3 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Parkwood LLC reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Parkwood LLC sold 8,477 Seagen Inc. Common Stock shares in Q4 2023, an estimated $1.8M.
  • Parkwood LLC first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 12 quarters.
  • Parkwood LLC's Seagen Inc. Common Stock position peaked at $3.7M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Parkwood LLC's 13F filing for Q4 2023, filed 14 Feb 2024.